Baseline Characteristics of All Patients Randomized in a Phase IIb Trial of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary Hypertension
Bildiriler > Özet Bildiri
Yazarlar: J. Behr, S.D. Nathan, S. Harari, W. Wuyts, N. Mogulkoc Bishop, D.E. Bouros, K. Antoniou, J. Guiot, M. Kramer, K.-U. Kirchgaessler, M. Bengus, F. Gilberg, A.U. Wells
B103. ILD: THERAPY, , , Uluslararası, Özet Bildiri, ss A4092-A4092
DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4092